2022 Cannabis Extraction Virtual Conference: September Program
Sponsored by Vanguard Scientific
Solvent Remediation – The Last Step for Safe, Clean Hemp ExtractionTom Bisbee, Production Director, EcoGen Biosciences
Attendees can expect to learn:Understanding solvent remediation technology and processes Residual solvents present huge risks Consumers deserve transparency
Advancing Cannabinoid Therapeutics Through Regulated Drug DiscoveryMatthew Anderson, CEO, Vanguard Scientific Nick Herbst, VP of Engineering, Vanguard Scientific Brian Brandley, Ph.D., Laboratory Director, Biopharmaceutical Research Co.
A panel discussion with Dr. Brian Brandley, the CSO of Biopharmaceutical Research Company, a DEA-licensed pharmaceutical company that is pioneering the legal cannabis space in the U.S. through the development of federally compliant active pharmaceutical ingredients (API) for plant-based therapeutics, and Nick Herbst, VP of Engineering at Vanguard Scientific, and the Lead Engineer for the Company’s MIDAS SCCO2 Extraction Program. During this 45-minute round table discussion moderated by Vanguard’s CEO Matthew Anderson, the panelists will provide an overview of what it takes to make ‘pharmaceutical-grade’ cannabis products. The conversation will range from facility requirements, methods development, equipment qualification, process validations and more.
GMPs for Cannabis Extraction: Don’t Overcomplicate itAndrew Cole, Director, Client Delivery Audits, Cannon Quality Group
Attendees can expect to learn:Understanding the basics in plain English. Learn what you need to do to meet minimum Industry expectations for Quality and Scalability. Implementation Strategies – Keep it simple.
© Cannabis Industry Journal